Tech Company Financing Transactions
Color Genomics Funding Round
On 9/28/2016, Color Genomics secured $45 million in Series B funding from General Catalyst Partners, 8VC and Emerson Collective.
Transaction Overview
Company Name
Announced On
9/28/2016
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Investors
General Catalyst Partners (Lead Investor) (Hemant Taneja)
private investors (Susan Wagner)
Proceeds Purpose
The new funding will go toward bringing even more people access to potentially life-saving genetic information and building the open databases necessary to further global research and development around major diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1801 Murchison Dr. 128
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Color provides a high-quality, physician-ordered, genetic test at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to breast and ovarian cancer genetic risk information for every person, everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elad Gil
VP - R & D
Alicia Zhou
Browse more venture capital transactions:
Prev: 9/28/2016: Speachme venture capital transaction
Next: 9/28/2016: Beckon venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs